These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quetiapine and rivastigmine for agitation in Alzheimer's disease. Ownby RL Curr Psychiatry Rep; 2006 Feb; 8(1):10. PubMed ID: 16513037 [No Abstract] [Full Text] [Related]
3. Alzheimer's disease: clinical evaluation and disease management--update. Richter RW J Okla State Med Assoc; 2004 Dec; 97(12):546-54; quiz 555-6. PubMed ID: 15732886 [No Abstract] [Full Text] [Related]
4. New developments in the treatment of Alzheimer's disease. J Clin Psychiatry; 2009 Feb; 70(2):281-90. PubMed ID: 19265644 [No Abstract] [Full Text] [Related]
5. Clinical inquiries. Do patients at high risk of Alzheimer's disease benefit from early treatment? Holt J; Stiltner L; Wallace R; Raetz J J Fam Pract; 2009 Jun; 58(6):320-2. PubMed ID: 19508846 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: recent advances in etiology, diagnosis, and management. Ahmed MB Tex Med; 2001 Dec; 97(12):50-8. PubMed ID: 11767466 [TBL] [Abstract][Full Text] [Related]
7. New tools for taking control of Alzheimer disease. Johns Hopkins Med Lett Health After 50; 2001 Dec; 13(10):4-5. PubMed ID: 11727444 [No Abstract] [Full Text] [Related]
8. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease. Raskind MA J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484 [TBL] [Abstract][Full Text] [Related]
9. [Treatment for non-cognitive symptoms in Alzheimer's disease]. Vilalta-Franch J; López-Pousa S; Llinàs-Reglà J Rev Neurol; 1999 Nov 1-15; 29(9):819-24. PubMed ID: 10696656 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Alzheimer's disease. Mayeux R; Sano M N Engl J Med; 1999 Nov; 341(22):1670-9. PubMed ID: 10572156 [No Abstract] [Full Text] [Related]
13. Alzheimer's disease. Answers to some of your questions. Mayo Clin Womens Healthsource; 2004 May; 8(5):1-2. PubMed ID: 15088007 [No Abstract] [Full Text] [Related]
15. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study. Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475 [No Abstract] [Full Text] [Related]
16. [In Alzheimer's disease, the clinical expression of behavioral and psychological signs and symptoms is early and specific of neuropathological stages]. Michel BF; Luciani V; Geda YE; Sambuchi N; Paban V; Azorin JM Encephale; 2010 Sep; 36(4):314-25. PubMed ID: 20850603 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: current knowledge, management and research. Gauthier S; Panisset M; Nalbantoglu J; Poirier J CMAJ; 1997 Oct; 157(8):1047-52. PubMed ID: 9347775 [TBL] [Abstract][Full Text] [Related]
18. [Therapy in Alzheimer disease]. Kovács T Orv Hetil; 2004 Apr; 145(17):925-8. PubMed ID: 15170971 [No Abstract] [Full Text] [Related]